Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08QYW
|
|||
| Drug Name |
CAR-T Cells targeting EpCAM
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Colon cancer [ICD-11: 2B90.Z] | Phase 1/2 | [1] | |
| Esophageal cancer [ICD-11: 2B70] | Phase 1/2 | [1] | ||
| Gastric adenocarcinoma [ICD-11: 2B72; ICD-9: 151] | Phase 1/2 | [1] | ||
| Hepatocellular carcinoma [ICD-11: 2C12.02; ICD-10: C22.0; ICD-9: 155] | Phase 1/2 | [1] | ||
| Pancreatic cancer [ICD-11: 2C10] | Phase 1/2 | [1] | ||
| Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Phase 1/2 | [1] | ||
| Company |
First Affiliated Hospital of Chengdu Medical College
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tumor-associated calcium signal transducer 1 (EPCAM) | Target Info | CAR-T-Cell-Therapy | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03013712) A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.